The forecasted hospital discharges for malignant neoplasm of the ovary in France, from 2024 to 2028, remain constant at 21.1 units per hundred thousand persons. This is notably consistent with the data from 2023, indicating no year-on-year percentage variation for the subsequent years. The data suggests a stable trend with no observed growth or decline (CAGR 0%).
Future trends to watch include advancements in early detection and treatment of ovarian cancer, which could influence discharge figures. Additionally, demographic changes and healthcare policy shifts in France may impact hospital discharge rates in the longer term.
